Zenas BioPharma, Inc. (ZBIO)
38.18
-1.19
(-3.02%)
USD |
NASDAQ |
Dec 09, 16:00
38.24
+0.06
(+0.17%)
After-Hours: 20:00
Zenas BioPharma Total Assets (Quarterly): 322.02M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Royalty Pharma Plc | 19.35B |
| Amgen, Inc. | 90.14B |
| Nektar Therapeutics | 301.35M |
| Rigel Pharmaceuticals, Inc. | 242.53M |
| Aquestive Therapeutics, Inc. | 163.56M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 125.59M |
| Shareholders Equity (Quarterly) | 196.43M |
| Debt to Equity Ratio | 0.0041 |
| Current Ratio | 5.659 |
| Net Debt Paydown Yield | -0.01% |